Home
Search
Study Topics
Glossary
|
|
|
|
|
Tracking Information | |||||
---|---|---|---|---|---|
First Received Date † | April 30, 2009 | ||||
Last Updated Date | April 30, 2009 | ||||
Start Date † | November 2008 | ||||
Current Primary Outcome Measures † |
PTSD symptoms [ Time Frame: pretreatment, weekly during treatment, posttreatment, followup ] [ Designated as safety issue: No ] | ||||
Original Primary Outcome Measures † | Same as current | ||||
Change History | No Changes Posted | ||||
Current Secondary Outcome Measures † |
General psychiatric symptoms [ Time Frame: pretreatment, weekly during treatment, postttreatment, followup ] [ Designated as safety issue: No ] | ||||
Original Secondary Outcome Measures † | Same as current | ||||
Descriptive Information | |||||
Brief Title † | Comparing Imaginal Exposure and Imagery Rescripting in Treatment of Posttraumatic Stress Disorder (PTSD) | ||||
Official Title † | Comparing Imaginal Exposure (IE) and Imagery Rescripting and Reprocessing Therapy (IRRT) in the Treatment of Posttraumatic Stress Disorder (PTSD) | ||||
Brief Summary | The outcome of trauma treatment (Posttraumatic Stress Disorder - PTSD) may be influenced by which emotions that are predominant among current symptoms, e.g. fear, anger, guilt, shame. Different treatment procedures for processing traumatic memories may resolve different emotions. This study compares two different treatment procedures of working with trauma memories in PTSD treatment (namely, Imaginal Exposure and Imagery Rescripting) in order to test this. |
||||
Detailed Description | The main objectives of this study are:
|
||||
Study Phase | |||||
Study Type † | Interventional | ||||
Study Design † | Treatment, Randomized, Single Blind (Outcomes Assessor), Active Control, Parallel Assignment, Efficacy Study | ||||
Condition † | Posttraumatic Stress Disorder | ||||
Intervention † |
|
||||
Study Arms / Comparison Groups | |||||
Publications * | |||||
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline. |
|||||
Recruitment Information | |||||
Recruitment Status † | Enrolling by invitation | ||||
Estimated Enrollment † | 64 | ||||
Estimated Completion Date | November 2012 | ||||
Estimated Primary Completion Date | November 2012 (final data collection date for primary outcome measure) | ||||
Eligibility Criteria † | Inclusion Criteria:
Exclusion Criteria:
|
||||
Gender | Both | ||||
Ages | 20 Years to 65 Years | ||||
Accepts Healthy Volunteers | No | ||||
Contacts †† | |||||
Location Countries † | Norway | ||||
Expanded Access Status | |||||
Administrative Information | |||||
NCT ID † | NCT00891098 | ||||
Responsible Party | Asle Hoffart, PhD., Modum Bad | ||||
Secondary IDs †† | |||||
Study Sponsor † | Modum Bad | ||||
Collaborators †† | University of Oslo | ||||
Investigators † |
|
||||
Information Provided By | Modum Bad | ||||
Verification Date | April 2009 | ||||
† Required WHO trial registration data element. †† WHO trial registration data element that is required only if it exists. |